Limor Rubin Selected Research

Limor Rubin Research Topics

5	COVID-19 01/2023 - 01/2022
3	Inflammation (Inflammations) 01/2024 - 01/2022
3	Hypersensitivity (Allergy) 10/2023 - 03/2022
2	Lung Diseases (Lung Disease) 01/2024 - 01/2021
2	Atopic Dermatitis (Atopic Eczema) 08/2023 - 01/2022
2	Exanthema (Rash) 04/2023 - 01/2022
2	Alzheimer Disease (Alzheimer's Disease) 01/2022 - 01/2022
1	Anaphylaxis (Anaphylactic Shock) 10/2023
1	Pruritus (Itching) 08/2023
1	Neoplasms (Cancer) 08/2023
1	Multiple Myeloma 04/2023
1	Delayed Hypersensitivity (Hypersensitivity, Type IV) 04/2023
1	Drug Hypersensitivity Syndrome 01/2023
1	Solar Urticaria 01/2023
1	Heart Arrest (Cardiac Arrest) 01/2023
1	Hemorrhage 01/2023
1	Infections 01/2023
1	Common Variable Immunodeficiency 03/2022
1	Eczema 01/2022
1	Chronic Mucocutaneous Candidiasis 01/2022
1	Job Syndrome (Hyper-IgE Syndrome) 01/2022
1	Ischemic Stroke 01/2022
1	Cytokine Release Syndrome 01/2022
1	Virus Diseases (Viral Diseases) 01/2022
1	Abscess 01/2022
1	Traumatic Brain Injuries (Traumatic Brain Injury) 01/2022
1	Epilepsy (Aura) 01/2022
1	Eosinophilia 01/2022
1	Nervous System Diseases (Neurological Disorders) 01/2022
1	Pancreatic Neoplasms (Pancreatic Cancer) 01/2022
1	Autoimmune Diseases (Autoimmune Disease) 12/2021
1	Experimental Autoimmune Encephalomyelitis (Encephalomyelitis, Autoimmune Experimental) 12/2021
1	Multiple Sclerosis 12/2021
1	Severe Acute Respiratory Syndrome 10/2021
1	Respiratory Tract Diseases (Respiratory Tract Disease) 01/2021

3	VaccinesIBA 01/2023 - 10/2021
2	CytokinesIBA 08/2023 - 01/2022
2	dupilumabIBA 08/2023 - 01/2022
2	Immunoglobulin E (IgE)IBA 03/2022 - 01/2022
1	AMP-Activated Protein KinasesIBA 01/2024
1	EnzymesIBA 01/2024
1	Adenosine (Adenocard)FDA LinkGeneric 01/2024
1	PowdersIBA 10/2023
1	Epinephrine (Adrenaline)FDA LinkGeneric 10/2023
1	Interleukin-4 (Interleukin 4)IBA 08/2023
1	Interleukin-13IBA 08/2023
1	Thalidomide (Thalomid)FDA Link 04/2023
1	Lenalidomide (CC 5013)FDA Link 04/2023
1	benralizumabIBA 01/2023
1	COVID-19 VaccinesIBA 01/2023
1	mRNA VaccinesIBA 01/2023
1	BNT162 VaccineIBA 01/2023
1	AllergensIBA 01/2023
1	Excipients (Suspending Agents)IBA 01/2023
1	Histamine Antagonists (Antihistamines)IBA 01/2023
1	Polyethylene Glycols (Polyethylene Glycol)FDA LinkGeneric 01/2023
1	Interleukin-5 (Interleukin 5)IBA 01/2023
1	ligelizumabIBA 01/2023
1	Immunomodulating AgentsIBA 12/2022
1	Antiviral Agents (Antivirals)IBA 12/2022
1	Immunoglobulins (Immunoglobulin)IBA 03/2022
1	Insulin-Like Growth Factor I (IGF-1)IBA 01/2022
1	STAT3 Transcription Factor (Signal Transducer and Activator of Transcription 3)IBA 01/2022
1	SteroidsIBA 01/2022
1	FibromodulinIBA 01/2022
1	Neuroprotective AgentsIBA 01/2022
1	Glutamic Acid (Glutamate)FDA Link 01/2022
1	IntegrinsIBA 12/2021
1	Monoclonal AntibodiesIBA 12/2021
1	Natalizumab (Tysabri)FDA Link 12/2021
1	Therapeutic UsesIBA 12/2021
1	Cyclic PeptidesIBA 12/2021
1	SolutionsIBA 10/2021
1	Nerve Growth Factors (Neurotrophins)IBA 01/2021